Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1991 Mar;67(785):223–226. doi: 10.1136/pgmj.67.785.223

Colchicine--expanding horizons.

A Schattner 1
PMCID: PMC2399002  PMID: 2062768

Full text

PDF
223

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alarcon-Segovia D., Ramos-Niembro F., Ibanez de Kasep G., Alcocer J., Tamayo R. P. Long-term evaluation of colchicine in the treatment of scleroderma. J Rheumatol. 1979 Nov-Dec;6(6):705–712. [PubMed] [Google Scholar]
  2. Alvarellos A., Spilberg I. Colchicine prophylaxis in pseudogout. J Rheumatol. 1986 Aug;13(4):804–805. [PubMed] [Google Scholar]
  3. Antoine J. C., Maurice M., Feldmann G., Avrameas S. In vivo and in vitro effects of colchicine and vinblastine on the secretory process of antibody-producing cells. J Immunol. 1980 Nov;125(5):1939–1949. [PubMed] [Google Scholar]
  4. Askari A. D. Colchicine for treatment of relapsing polychondritis. J Am Acad Dermatol. 1984 Mar;10(3):507–510. doi: 10.1016/s0190-9622(84)80102-4. [DOI] [PubMed] [Google Scholar]
  5. Bauer E. A., Valle K. J. Colchicine-induced modulation of collagenase in human skin fibroblast cultures. I. Stimulation of enzyme synthesis in normal cells. J Invest Dermatol. 1982 Dec;79(6):398–402. doi: 10.1111/1523-1747.ep12530243. [DOI] [PubMed] [Google Scholar]
  6. Benson M. D. Treatment of AL amyloidosis with melphalan, prednisone, and colchicine. Arthritis Rheum. 1986 May;29(5):683–687. doi: 10.1002/art.1780290515. [DOI] [PubMed] [Google Scholar]
  7. Bodenheimer H., Jr, Schaffner F., Pezzullo J. Evaluation of colchicine therapy in primary biliary cirrhosis. Gastroenterology. 1988 Jul;95(1):124–129. doi: 10.1016/0016-5085(88)90300-9. [DOI] [PubMed] [Google Scholar]
  8. Boyer J. L., Ransohoff D. F. Is colchicine effective therapy for cirrhosis? N Engl J Med. 1988 Jun 30;318(26):1751–1752. doi: 10.1056/NEJM198806303182609. [DOI] [PubMed] [Google Scholar]
  9. Callen J. P. Colchicine is effective in controlling chronic cutaneous leukocytoclastic vasculitis. J Am Acad Dermatol. 1985 Aug;13(2 Pt 1):193–200. doi: 10.1016/s0190-9622(85)70158-2. [DOI] [PubMed] [Google Scholar]
  10. Cohen A. S., Rubinow A., Anderson J. J., Skinner M., Mason J. H., Libbey C., Kayne H. Survival of patients with primary (AL) amyloidosis. Colchicine-treated cases from 1976 to 1983 compared with cases seen in previous years (1961 to 1973). Am J Med. 1987 Jun;82(6):1182–1190. doi: 10.1016/0002-9343(87)90222-1. [DOI] [PubMed] [Google Scholar]
  11. Dinarello C. A., Wolff S. M., Goldfinger S. E., Dale D. C., Alling D. W. Colchicine therapy for familial mediterranean fever. A double-blind trial. N Engl J Med. 1974 Oct 31;291(18):934–937. doi: 10.1056/NEJM197410312911804. [DOI] [PubMed] [Google Scholar]
  12. Ferrannini E., Pentimone F. Marrow aplasia following colchicine treatment for gouty arthritis. Clin Exp Rheumatol. 1984 Apr-Jun;2(2):173–175. [PubMed] [Google Scholar]
  13. Granat M., Tur-Kaspa I., Zylber-Katz E., Schenker J. G. Reduction of peritoneal adhesion formation by colchicine: a comparative study in the rat. Fertil Steril. 1983 Sep;40(3):369–372. doi: 10.1016/s0015-0282(16)47302-4. [DOI] [PubMed] [Google Scholar]
  14. Kaplan M. M., Alling D. W., Zimmerman H. J., Wolfe H. J., Sepersky R. A., Hirsch G. S., Elta G. H., Glick K. A., Eagen K. A. A prospective trial of colchicine for primary biliary cirrhosis. N Engl J Med. 1986 Dec 4;315(23):1448–1454. doi: 10.1056/NEJM198612043152304. [DOI] [PubMed] [Google Scholar]
  15. Kershenobich D., Vargas F., Garcia-Tsao G., Perez Tamayo R., Gent M., Rojkind M. Colchicine in the treatment of cirrhosis of the liver. N Engl J Med. 1988 Jun 30;318(26):1709–1713. doi: 10.1056/NEJM198806303182602. [DOI] [PubMed] [Google Scholar]
  16. Knecht A., de Beer F. C., Pras M. Serum amyloid A protein in familial Mediterranean fever. Ann Intern Med. 1985 Jan;102(1):71–72. doi: 10.7326/0003-4819-102-1-71. [DOI] [PubMed] [Google Scholar]
  17. Kuncl R. W., Duncan G., Watson D., Alderson K., Rogawski M. A., Peper M. Colchicine myopathy and neuropathy. N Engl J Med. 1987 Jun 18;316(25):1562–1568. doi: 10.1056/NEJM198706183162502. [DOI] [PubMed] [Google Scholar]
  18. Kyle R. A., Greipp P. R., Garton J. P., Gertz M. A. Primary systemic amyloidosis. Comparison of melphalan/prednisone versus colchicine. Am J Med. 1985 Dec;79(6):708–716. doi: 10.1016/0002-9343(85)90521-2. [DOI] [PubMed] [Google Scholar]
  19. Leiser A., Kadish U. Beneficial effect of colchicine in a case of sclerosing cholangitis. Am J Med Sci. 1986 Jun;291(6):416–418. doi: 10.1097/00000441-198606000-00008. [DOI] [PubMed] [Google Scholar]
  20. Lemor M., Yeo J. H., Glaser B. M. Oral colchicine for the treatment of experimental traction retinal detachment. Arch Ophthalmol. 1986 Aug;104(8):1226–1229. doi: 10.1001/archopht.1986.01050200132067. [DOI] [PubMed] [Google Scholar]
  21. Livingstone R. R., Sarembock L. A., Barnes R. D., Folb P. I. Colchicine therapy in primary amyloidosis of the bladder: a case report. J Urol. 1989 Dec;142(6):1570–1571. doi: 10.1016/s0022-5347(17)39168-1. [DOI] [PubMed] [Google Scholar]
  22. Lyons M. J., Amador R., Petito C., Nagashima K., Weinreb H., Zabriskie J. B. Inhibition of acute experimental allergic encephalomyelitis in mice by colchicine. J Exp Med. 1986 Nov 1;164(5):1803–1808. doi: 10.1084/jem.164.5.1803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Malkinson F. D. Colchicine. New uses of an old, old drug. Arch Dermatol. 1982 Jul;118(7):453–457. doi: 10.1001/archderm.118.7.453. [DOI] [PubMed] [Google Scholar]
  24. Masuda K., Nakajima A., Urayama A., Nakae K., Kogure M., Inaba G. Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease. Lancet. 1989 May 20;1(8647):1093–1096. doi: 10.1016/s0140-6736(89)92381-7. [DOI] [PubMed] [Google Scholar]
  25. Mekori Y. A., Chowers Y., Ducker I., Klajman A. Inhibition of delayed hypersensitivity reactions by colchicine. II. Colchicine inhibits interferon-gamma induced expression of HLA-DR on gut epithelial cell line. Clin Exp Immunol. 1989 Nov;78(2):230–232. [PMC free article] [PubMed] [Google Scholar]
  26. Meyers S., Janowitz H. D., Gumaste V. V., Abramson R. G., Berman L. J., Venkataseshan V. S., Dickman S. H. Colchicine therapy of the renal amyloidosis of ulcerative colitis. Gastroenterology. 1988 Jun;94(6):1503–1507. doi: 10.1016/0016-5085(88)90692-0. [DOI] [PubMed] [Google Scholar]
  27. Milner L. S., Lotan D., Mills M., Goodyer P. R., Fong J. S., Kaplan B. S. Colchicine reduces proteinuria in passive Heymann nephritis. Nephron. 1987;46(1):11–17. doi: 10.1159/000184288. [DOI] [PubMed] [Google Scholar]
  28. Miyachi Y., Niwa Y. Effects of potassium iodide, colchicine and dapsone on the generation of polymorphonuclear leukocyte-derived oxygen intermediates. Br J Dermatol. 1982 Aug;107(2):209–214. doi: 10.1111/j.1365-2133.1982.tb00340.x. [DOI] [PubMed] [Google Scholar]
  29. Mizushima Y., Matsumura N., Mori M., Shimizu T., Fukushima B., Mimura Y., Saito K., Sugiura S. Colchicine in Behçet's disease. Lancet. 1977 Nov 12;2(8046):1037–1037. doi: 10.1016/s0140-6736(77)92945-2. [DOI] [PubMed] [Google Scholar]
  30. Mourelle M., Fraginals R., Rodríguez L., Favari L., Pérez-Alvarez V. Protective effect of colchiceine against acute liver damage. Life Sci. 1989;45(10):891–900. doi: 10.1016/0024-3205(89)90203-8. [DOI] [PubMed] [Google Scholar]
  31. Mourelle M., Villalon C., Amezcua J. L. Protective effect of colchicine on acute liver damage induced by carbon tetrachloride. J Hepatol. 1988 Jun;6(3):337–342. doi: 10.1016/s0168-8278(88)80051-5. [DOI] [PubMed] [Google Scholar]
  32. Plotnick S., Huppert A. S., Kantor G. Colchicine and leukocytoclastic vasculitis. Arthritis Rheum. 1989 Nov;32(11):1489–1490. doi: 10.1002/anr.1780321125. [DOI] [PubMed] [Google Scholar]
  33. Roberts W. N., Liang M. H., Stern S. H. Colchicine in acute gout. Reassessment of risks and benefits. JAMA. 1987 Apr 10;257(14):1920–1922. [PubMed] [Google Scholar]
  34. Rodríguez de la Serna A., Guindo Soldevila J., Martí Claramunt V., Bayés de Luna A. Colchicine for recurrent pericarditis. Lancet. 1987 Dec 26;2(8574):1517–1517. doi: 10.1016/s0140-6736(87)92641-9. [DOI] [PubMed] [Google Scholar]
  35. Ruah C. B., Stram J. R., Chasin W. D. Treatment of severe recurrent aphthous stomatitis with colchicine. Arch Otolaryngol Head Neck Surg. 1988 Jun;114(6):671–675. doi: 10.1001/archotol.1988.01860180085037. [DOI] [PubMed] [Google Scholar]
  36. Sander H. M., Randle H. W. Use of colchicine in Behçet's syndrome. Cutis. 1986 May;37(5):344–348. [PubMed] [Google Scholar]
  37. Schattner A., Varon D., Green L., Hurwitz N., Bentwich Z. Primary amyloidosis with unusual bone involvement: reversibility with melphalan, prednisone, and colchicine. Am J Med. 1989 Mar;86(3):347–348. doi: 10.1016/0002-9343(89)90312-4. [DOI] [PubMed] [Google Scholar]
  38. Seideman P., Fjellner B., Johannesson A. Psoriatic arthritis treated with oral colchicine. J Rheumatol. 1987 Aug;14(4):777–779. [PubMed] [Google Scholar]
  39. Shahar E., Keidar I., Hertzeg E., Barzilay Z. Effectiveness of vitamin E and colchicine in amelioration of paraquat lung injuries using an experimental model. Isr J Med Sci. 1989 Feb;25(2):92–94. [PubMed] [Google Scholar]
  40. Silvers D. N., Juhlin E. A., Berczeller P. H., McSorley J. Treatment of dermatitis herpetiformis with colchicine. Arch Dermatol. 1980 Dec;116(12):1373–1384. [PubMed] [Google Scholar]
  41. Spilberg I., Mandell B., Mehta J., Simchowitz L., Rosenberg D. Mechanism of action of colchicine in acute urate crystal-induced arthritis. J Clin Invest. 1979 Sep;64(3):775–780. doi: 10.1172/JCI109523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Strother S. V., Zuckerman K. S., LoBuglio A. F. Colchicine therapy for refractory idiopathic thrombocytopenic purpura. Arch Intern Med. 1984 Nov;144(11):2198–2200. [PubMed] [Google Scholar]
  43. Tanner M. S., Jackson D., Mowat A. P. Hepatic collagen synthesis in a rat model of cirrhosis, and its modification by colchicine. J Pathol. 1981 Nov;135(3):179–187. doi: 10.1002/path.1711350303. [DOI] [PubMed] [Google Scholar]
  44. Theodors A., Askari A. D., Wieland R. G. Colchicine in the treatment of Paget disease of bone: a new therapeutic approach. Clin Ther. 1981;3(5):365–373. [PubMed] [Google Scholar]
  45. Trinchet J. C., Beaugrand M., Callard P., Hartmann D. J., Gotheil C., Nusgens B. V., Lapiere C. M., Ferrier J. P. Treatment of alcoholic hepatitis with colchicine. Results of a randomized double blind trial. Gastroenterol Clin Biol. 1989 Jun;13(6-7):551–555. [PubMed] [Google Scholar]
  46. Wahl S. M., Wahl L. M., McCarthy J. B. Lymphocyte-mediated activation of fibroblast proliferation and collagen production. J Immunol. 1978 Sep;121(3):942–946. [PubMed] [Google Scholar]
  47. Wallace S. L., Singer J. Z. Review: systemic toxicity associated with the intravenous administration of colchicine--guidelines for use. J Rheumatol. 1988 Mar;15(3):495–499. [PubMed] [Google Scholar]
  48. Werni R., Schwarz T., Gschnait F. Colchicine treatment of urticarial vasculitis. Dermatologica. 1986;172(1):36–40. doi: 10.1159/000249290. [DOI] [PubMed] [Google Scholar]
  49. Yü T. The efficacy of colchicine prophylaxis in articular gout--a reappraisal after 20 years. Semin Arthritis Rheum. 1982 Nov;12(2):256–264. doi: 10.1016/0049-0172(82)90065-8. [DOI] [PubMed] [Google Scholar]
  50. Zemer D., Pras M., Sohar E., Modan M., Cabili S., Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med. 1986 Apr 17;314(16):1001–1005. doi: 10.1056/NEJM198604173141601. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES